Copyright
©The Author(s) 2017.
World J Hepatol. Jul 8, 2017; 9(19): 850-856
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.850
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.850
Test | End point | AUROC |
Baseline Hepascore alone | Composite endpoint | 0.80 |
LRD | 0.89 | |
LD | 0.75 | |
HCC | 0.87 | |
Baseline Hepascore > 0.75 and Delta Hepascore | Composite endpoint | 0.84 |
LRD | 0.95 | |
LD | 0.77 | |
HCC | 0.93 |
- Citation: Jeffrey AW, Huang Y, de Boer WB, Adams LA, MacQuillan G, Speers D, Joseph J, Jeffrey GP. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World J Hepatol 2017; 9(19): 850-856
- URL: https://www.wjgnet.com/1948-5182/full/v9/i19/850.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i19.850